Back to Awarded Treatment Trials
Awarded Trial: 03T-327
Grant ID
03T-327
Illness
Schizophrenia
Primary Drug/Intervention
Atomoxetine
Primary Dosage
40mg bid
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Ganguli
Sample Size
60
Duration of Study Period for Each Subject
26 weeks
Outcome Measurements
SANS, PANSS, Calgary Depression Scale, GAF, CGI, cognitive battery
Results
There were no significant differences between atomoxetine and placebo using an intent-to-treat (n=60) and a complete analysis (n=30).
Publication
N/A
Link
N/A
PI Name
Rohan Ganguli
Degree
MD
Center
N/A
Institution
Western Psychiatric Institute and Clinic
Address
3811 O'Hara Street, Room E820
City or Town
Pittsburgh
State or Province
PA
Zip or Postal Code
15213
Country
USA
Email Address
gangulir@msx.upmc.edu